Delivery Order 36F79724D0026-36C24825N0605
Award Date
4/8/25
Potential Completion Date
4/11/25
Potential Value
$44K
Federal Agency
Veterans Integrated Service Network 8
Awardee
Immunocore Commercial LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded to Immunocore Commercial LLC, a foreign-owned, for-profit manufacturer of pharmaceutical products, for the supply of KIMMTRAK (tebentafusp-tebn), a 100MCG/0.5ML injectable pharmaceutical product. The $14,800.35 firm fixed-price contract, awarded by the U.S. Department of Veterans Affairs (VA) through the Veterans Integrated Service Network 9 (VISN 9), has an ultimate completion date of March 31, 2025. Immunocore Commercial LLC holds a Federal Supply Schedule...
This federal contract award was issued by the U.S. Department of Veterans Affairs (VA) to Immunocore Commercial LLC, a foreign-owned, for-profit manufacturer of pharmaceutical goods. The $28,895.66 firm fixed-price delivery order is for the supply of KIMMTRAK (tebentafusp-tebn) 100MCG/0.5ML injectable pharmaceutical product to the VA's Veterans Integrated Service Network (VISN) 21.
Immunocore Commercial LLC is the prime contractor and holds two Federal Supply Schedule (FSS) Indefinite...
This federal contract award is for the delivery of KIMMTRAK (tebentafusp-tebn), a 100MCG/0.5ML injectable pharmaceutical product, to the U.S. Department of Veterans Affairs (VA). The contract was awarded to Immunocore Commercial LLC, a foreign-owned, for-profit manufacturer of goods, on December 2, 2024 as Delivery Order 36F79724D0026|36C26125N0252 with a ceiling value of $86,686.98. The contract is a firm fixed-price delivery order with an ultimate completion date of February 14, 2025....
This federal contract award is for the delivery of KIMMTRAK (tebentafusp-tebn), a 100MCG/0.5ML injectable pharmaceutical product, to the U.S. Department of Veterans Affairs (VA). The contract was awarded to Immunocore Commercial LLC, a foreign-owned, for-profit manufacturer of goods, as a delivery order under Federal Supply Schedule (FSS) Indefinite Delivery Vehicle (IDV) contract 36F79724D0026. This IDV, with a $225,000 ceiling value and an ultimate completion date of November 14, 2028,...
This federal contract award is for the delivery of KIMMTRAK (tebentafusp-tebn), a 100MCG/0.5ML injectable pharmaceutical product, to the U.S. Department of Veterans Affairs (VA). The contract was awarded to Immunocore Commercial LLC, a foreign-owned, for-profit manufacturer of goods, and is a Firm Fixed Price Delivery Order under the company's $225,000 Federal Supply Schedule (FSS) Indefinite Delivery Vehicle (IDV) contract 36F79724D0026. This IDV covers Federal Supply Classification 65 I B,...
This federal contract award is for the delivery of the pharmaceutical product KIMMTRAK (tebentafusp-tebn) to the U.S. Department of Veterans Affairs (VA). The prime contractor is Immunocore Commercial LLC, a foreign-owned, for-profit manufacturer of goods. The contract was awarded on February 14, 2025 with a ceiling value of $44,179.05 and an ultimate completion date of March 31, 2025. The contract is a Firm Fixed Price Delivery Order, and no set-aside was used. Immunocore Commercial LLC...
This federal contract award is for the delivery of KIMMTRAK (tebentafusp-tebn) 100MCG/0.5ML vials, an injectable pharmaceutical product, to the U.S. Department of Veterans Affairs (VA). The prime contractor, Immunocore Commercial LLC, is a foreign-owned, for-profit manufacturer of goods registered in the System for Award Management (SAM.gov). The contract, a firm fixed-price delivery order with a ceiling value of $86,686.98, was awarded on October 11, 2024, with an ultimate completion date of...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $80,218.40 and a completion date of May 6, 2024. It is for the delivery of Keytruda 100 mg/4 ml vials, a cancer immunotherapy drug, to support the medical supply needs of military health facilities.
This delivery order is part of a larger indefinite...
This is a delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Novartis Pharmaceuticals Corporation, a foreign-owned, for-profit manufacturer, to provide the chimeric antigen receptor T-cell therapy drug Kymriah. The order, valued at $283,567.92, was placed against Novartis' Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB) and has a firm fixed price. The order supports the VA's medical programs and does not have a...
This federal contract award to Novartis Pharmaceuticals Corporation, doing business as NPS, is for the delivery of Kymriah, a specialized cell therapy cancer treatment, to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract is issued as a delivery order against Novartis' existing Federal Supply Schedule (FSS) 61-IB contract for pharmaceuticals and drugs, which has a potential value of $5.4 billion and runs through August 2025. The specific delivery...